HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 86 filers reported holding HOMOLOGY MEDICINES INC in Q4 2019. The put-call ratio across all filers is 81.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $123,000 | -7.5% | 33,898 | +100.0% | 0.00% | – |
| Q3 2021 | $133,000 | +23.1% | 16,949 | 0.0% | 0.00% | – |
| Q2 2021 | $108,000 | -77.8% | 16,949 | -67.2% | 0.00% | -100.0% |
| Q1 2021 | $487,000 | -9.0% | 51,723 | +9.2% | 0.00% | 0.0% |
| Q4 2020 | $535,000 | -14.5% | 47,375 | -19.0% | 0.00% | 0.0% |
| Q3 2020 | $626,000 | -29.5% | 58,471 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $888,000 | +1.6% | 58,471 | +3.9% | 0.00% | 0.0% |
| Q1 2020 | $874,000 | -35.5% | 56,271 | -14.0% | 0.00% | -50.0% |
| Q4 2019 | $1,355,000 | +9.8% | 65,442 | -4.0% | 0.00% | 0.0% |
| Q3 2019 | $1,234,000 | +31.0% | 68,171 | +41.7% | 0.00% | +100.0% |
| Q2 2019 | $942,000 | +21.9% | 48,119 | +72.7% | 0.00% | 0.0% |
| Q1 2019 | $773,000 | +43.7% | 27,868 | +15.8% | 0.00% | 0.0% |
| Q4 2018 | $538,000 | +1.5% | 24,068 | +3.9% | 0.00% | 0.0% |
| Q3 2018 | $530,000 | +17.8% | 23,168 | +5.0% | 0.00% | 0.0% |
| Q2 2018 | $450,000 | +9.0% | 22,068 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $413,000 | – | 22,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $13,789,000 | 3.01% |
| Vida Ventures Advisors, LLC | 770,845 | $2,343,000 | 1.36% |
| Vivo Capital, LLC | 853,143 | $2,594,000 | 0.18% |
| OUP Management Co., LLC | 64,000 | $195,000 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 214,898 | $653,000 | 0.13% |
| AAF Wealth Management, LLC | 47,501 | $144,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 228,365 | $694,000 | 0.09% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $17,179,028 | 0.07% |
| Bellevue Group AG | 1,647,122 | $5,007,000 | 0.06% |
| Virtus ETF Advisers LLC | 35,487 | $108,000 | 0.05% |